Parexel
The appointment of Greg Rush as executive vice president and chief financial officer at Parexel follows much speculation on the matter earlier this year.
Rush, who held the same roles at Syneos Health from August 2013 to August 2017, announced his early departure from the company in February and remained on paid leave through April 30, 2018.
“After leading global financial operations within the CRO and service industries for many years, I am thrilled to be joining Parexel, a company that has helped so many life science companies deliver new therapies to patients. In my role as executive vice president and chief financial officer, my goal is to position Parexel for successful growth so we are able to better deliver for our clients and enable them to bring important new treatments to market,” Rush told us.
His appointment became effective August 20, 2018. He is based at Parexel’s corporate headquarters in Waltham, Massachusetts.
At Parexel, Rush joins with his former INC Research colleague, Jamie Macdonald, who was named CEO of the company in March.
Parexel also in August named Michele Fournier as senior vice president and chief human resources officer.
Fourier has been with the company since 2014 and was serving as corporate vice president and interim chief human resources officer since January 2018. Previously, Fournier was corporate vice president for compensation, benefits, and HR M&A.